The company argues that claims of underperformance should be judged against a meaningful, comparable benchmark.

VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...

Archaeologists from Lancaster University have recovered a sixth-century sword from an Anglo-Saxon cemetery near Canterbury, ...

Smart glasses come in more forms than most people realize. After reviewing more than 20 pairs, I'm breaking down what's out ...

NovaBridge (NBP) is rated Sell due to limited market opportunity, intense competition, and high cash burn overshadowing its ...

School-based programmes may prevent adolescents from starting to use electronic cigarettes (e-cigarettes) and a community-based programme delivered by text message probably helps adolescents quit ...

Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded ...

Both a DEA lawyer and an FDA official spoke to justify rescheduling—arguments that were condemned by a prominent ...

Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE studyPUL 2.0 year-over-year decline ...

Following semaglutide's approval, poison center reports of GLP-1 RA exposures doubled, revealing critical trends in patient ...

Antenatal balanced energy-protein (BEP) dietary supplementation is a WHO recommendation in undernourished settings, but ...